Pasar al contenido principal

Refine your results

Filtros
Buscar
Include spaces in matter number if applicable. Ex.: 182 3125
Fecha
Displaying 861 - 880 of 18303
Cases and Proceedings
Commissioner Statements

Statement of Commissioner Rebecca Kelly Slaughter Joined by Chair Lina M. Khan and Commissioner Alvaro M. Bedoya Regarding the Issuance of a Notice of Penalty Offenses on Substantiation of Product Claims

… of a Notice of Penalty Offenses on Substantiation of Product Claims Statement of Commissioner Rebecca Kelly … of a Notice of Penalty Offenses on Substantiation of Product Claims … Statement of Commissioner Rebecca Kelly … of a Notice of Penalty Offenses on Substantiation of Product Claims …
Date
By
Rebecca Kelly Slaughter, Commissioner;
Lina M. Khan, Former Chair and Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
P224502
Cases and Proceedings
Commissioner Statements

Dissenting Statement of Commissioner Christine S. Wilson Regarding the Issuance of a Notice of Penalty Offenses on Substantiation of Product Claims

… of a Notice of Penalty Offenses on Substantiation of Product Claims Dissenting Statement of Commissioner … of a Notice of Penalty Offenses on Substantiation of Product Claims … Dissenting Statement of Commissioner … of a Notice of Penalty Offenses on Substantiation of Product Claims …
Date
By
Christine S. Wilson, Former Commissioner
Matter Number
P224502
Testimony

Prepared Statement of the Federal Trade Commission: Hearing on Compliance with Committee Oversight

… Prepared Statement of the Federal Trade Commission: Hearing on Compliance with Committee Oversight Prepared Statement of the Federal Trade Commission: Hearing on Compliance with Committee Oversight … Prepared Statement of the Federal Trade Commission: Hearing …
Date
Matter Number
P210100
HSR Informal Interpretations

2303003 Informal Interpretation

… 2303003 Informal Interpretation 2303003 Informal Interpretation From: Whitehead, Nora <nwhitehead@ftc.gov> Sent: Monday, March 27, 2023 2:16:42 PM (UTC-05:00) … Time (US & Canada) To: [Redacted] Cc: HSRHelp <HSRHelp@ftc.gov> Subject: RE: Question concerning Item 6(a) Report …
Date
Rule
Item 6(a)
Report all controlled US entities, regardless of whether they have sales in or into the US (subject to the $10MM threshold you reference below). For more guidance, see https://www.ftc.gov/enforcement...
Cases and Proceedings
Commissioner Statements

Dissenting Statement of Commissioner Christine S. Wilson regarding the Negative Option Rule NPRM

… Christine S. Wilson regarding the Negative Option Rule NPRM Dissenting Statement of Commissioner Christine S. Wilson regarding the Negative Option Rule NPRM … Dissenting Statement of Commissioner Christine S. Wilson regarding the Negative Option Rule NPRM …
Date
By
Christine S. Wilson, Former Commissioner
Cases and Proceedings
Commissioner Statements

Statement of Chair Lina M. Khan Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule

… and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule Statement of … and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule … Statement … and Commissioner Alvaro M. Bedoya Regarding the Notice of Proposed Rulemaking on the Negative Option Rule …
Date
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Commissioner;
Alvaro Bedoya, Former Commissioner
Matter Number
P064202
Amicus Briefs

Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al.

… et al. v. Supernus Pharmaceuticals, Inc. Amicus Brief DI-93-FTC-amicus-brief-docketed.pdf … Sage Chemical, Inc. et al. …
Date
Federal Court
District of Delaware
The Federal Trade Commission filed an amicus brief with the U.S. District Court for the District of Delaware in the case of Sage Chemical, Inc. et al. v. Supernus Pharmaceuticals, Inc. et al. The...
Cases and Proceedings

Dalal A. Akoury d/b/a AWAREmed, et al., U.S. v.

… Akoury d/b/a AWAREmed, et al., U.S. v. In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act , suing Dr. Dalal A. Akoury and a set of … and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. …

In March 2023, the FTC took action under the Opioid Addiction Recovery Fraud Prevention Act, suing Dr. Dalal A. Akoury and a set of companies she controls that operate as AWAREmed Health & Wellness Resource Center, a medical clinic, for making a wide range of false or unsupported claims for addiction treatment services, cancer treatment services, and the treatment of other serious conditions. The proposed order settling the Commission’s complaint bars Dr. Akoury and her AWAREmed clinic from making such unsupported claims and requires her to pay a $100,000 civil penalty.

 

Type of Action
Federal
Last Updated
FTC Matter/File Number
2123039
Docket Number
2:23-CV-00026
Case Status
Pending
Displaying 861 - 880 of 18303
Return to top